Clinical Trials Browser

Completed × Neoplasms × CYC065 × Clear all

NCT02552953 2024-05-31

A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers

Phase 1 Completed

Neoplasms